Send me a link:

*Text messaging rates may apply.

 Dow Up 0.17% Nasdaq Up 0.44%

Geron Corporation (GERN)

-NasdaqGS
3.00 Up 0.09(3.09%) Jul 11, 4:00PM EDT
Prev Close:2.91
Open:2.91
Bid:2.93 x 5000
Ask:3.04 x 900
1y Target Est:4.13
Beta:2.49
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:2.90 - 3.04
52wk Range:1.27 - 7.79
Volume:2,359,423
Avg Vol (3m):4,385,270
Market Cap:470.81M
P/E (ttm):N/A
EPS (ttm):-0.26
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GERNUp 3.09%470.81M
BMYUp 0.23%80.57B
GSKDown 1.27%129.28B
NVSDown 0.32%219.04B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):460.37
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.25
Quarterly EPS Est (Jun-14) :-0.06
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):-2.33

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, develops a telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback